Millennium Management’s Haemonetics HAE Stock Holding History

Millennium Management’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-20,000	Closed	-$1.49M	–	6191
2025 Q2	$1.49M	Buy	20,000 +15,000	+300%	+$993K	﹤0.01%	4119
2025 Q1	$318K	Buy	+5,000	New	+$340K	﹤0.01%	5071
2024 Q1	–	Sell	-20,000	Closed	-$1.71M	–	6369
2023 Q4	$1.71M	Buy	+20,000	New	+$1.73M	﹤0.01%	3731
2023 Q1	–	Sell	-15,000	Closed	-$1.18M	–	6559
2022 Q4	$1.18M	Buy	+15,000	New	+$1.21M	﹤0.01%	4001
2021 Q3	–	Sell	-10,000	Closed	-$666K	–	6963
2021 Q2	$666K	Sell	10,000 -20,000	-67%	-$1.42M	﹤0.01%	5041
2021 Q1	$3.33M	Hold	30,000	–	–	﹤0.01%	3028
2020 Q4	$3.56M	Buy	+30,000	New	+$3.23M	﹤0.01%	2770

Other funds holding HAE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

RRAM

River Road Asset Management Louisville, Kentucky $8.82B AUM 7.52% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Millennium Management's HAE Position: Q1 2026 in Review

Millennium Management reduced its Haemonetics (HAE) stake by 82% in Q1 2026, selling an estimated $2.93M and leaving 9,784 shares worth $551K. The position accounts for ﹤0.01% of the portfolio, ranked #4712.

Millennium Management first reported a position in HAE in Q2 2013 and has held it in 51 quarters since. The position peaked at $86.6M in Q1 2018. 324 funds tracked by Wall St. Rank hold HAE as of Q1 2026.

Millennium Management held 9,784 shares of Haemonetics worth $551K as of Q1 2026.
Millennium Management sold 45,037 Haemonetics shares in Q1 2026, an estimated $2.93M.
Haemonetics made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #4712 holding.
Millennium Management first reported a position in Haemonetics in Q2 2013 and has held it in 51 quarters since.
Millennium Management's Haemonetics position peaked at $86.6M in Q1 2018.
324 funds tracked by Wall St. Rank held Haemonetics as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.